tirzepatide and heart Tirzepatide, initially approved for Type 2 diabetes weight management, is emerging as a promising treatment for failure. Recent studies indicate that it not only reduces the risk of heart… How the weight loss drug

Learn how standard titration and microdosing compare and why a licensed provider should guide your dosing plan.

This guide explores prescription options, compounded alternatives, and how genetic and biomarker factors may inform provider conversations about suitability

Gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal pain are among the most frequently reported side effects, especially at the start of treatment

Random-effects models were applied, and sensitivity analyses examined result stability

Abdominal rumbling (borborygmi) on GLP-1 receptor agonist therapy is caused by delayed gastric emptying and altered gastrointestinal motility, and should be ...